Amyloid PET Linked to Changes in Management for MCI, Dementia

TUESDAY, April 2, 2019 -- For Medicare beneficiaries with mild cognitive impairment (MCI) or dementia of uncertain etiology, amyloid positron emission tomography (PET) is associated with changes in clinical management, according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news